IL-8 as Antibody Therapeutic Target in Inflammatory Diseases: Reduction of Clinical Activity in Palmoplantar Pustulosis-Reference-Cited by-同舟云学术

IL-8 as Antibody Therapeutic Target in Inflammatory Diseases: Reduction of Clinical Activity in Palmoplantar Pustulosis

Published:2008-06-19 Issue:1 Volume:181 Page:669-679
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J Immunol

Author:

Skov Lone,Beurskens Frank J.,Zachariae Claus O. C.,Reitamo Sakari,Teeling Jessica,Satijn David,Knudsen Kim M.,Boot Elmieke P. J.,Hudson Debra,Baadsgaard Ole,Parren Paul W. H. I.,van de Winkel Jan G. J.

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference46 articles.

1. Interleukin 8 as a novel target for intervention therapy in acute inflammatory diseases

2. Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines.

3. Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor.

4. Purification and amino acid sequencing of NAF, a novel neutrophil-activating factor produced by monocytes

Cited by 144 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exposure to ambient air pollution mixture and senescence-associated secretory phenotype proteins among middle-aged and older women;Environmental Research;2024-11

2. Evaluation of THP-1 and Jurkat Cell Lines Coculture for the In Vitro Assessment of the Effects of Immunosuppressive Substances;Toxics;2024-08-19

3. Exploratory Efficacy Evaluation of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: 32-Week Results from a Phase 2, Randomized, Placebo-Controlled Study;Dermatology and Therapy;2024-06-19

4. Porcine cis-acting lnc-CAST positively regulates CXCL8 expression through histone H3K27ac;Veterinary Research;2024-05-07

5. Navigating IL-6: From molecular mechanisms to therapeutic breakthroughs;Cytokine & Growth Factor Reviews;2024-04